Abstract
Leishmaniasis is a vector-borne disease with a complex epidemiology and ecology. Visceral leishmaniasis (VL) is its most severe clinical form as it results in death if not treated. In Latin America VL is caused by the protist parasite Leishmania infantum (syn. chagasi) and transmitted by Lutzomyia longipalpis. This phlebotomine sand fly is only found in the New World, from Mexico to Argentina. However, due to deforestation, migration and urbanisation, among others, VL in Latin America is undergoing an evident geographic expansion as well as dramatic changes in its transmission patterns. In this context, the first VL outbreak was recently reported in Argentina, which has already caused 7 deaths and 83 reported cases.Insect vector transcriptomic analyses enable the identification of molecules involved in the insect's biology and vector-parasite interaction. Previous studies on laboratory reared Lu. longipalpis have provided a descriptive repertoire of gene expression in the whole insect, midgut, salivary gland and male reproductive organs. Nevertheless, the study of wild specimens would contribute a unique insight into the development of novel bioinsecticides. Given the recent VL outbreak in Argentina and the compelling need to develop appropriate control strategies, this study focused on wild male and female Lu. longipalpis from an Argentine endemic (Posadas, Misiones) and a Brazilian non-endemic (Lapinha Cave, Minas Gerais) VL location. In this study, total RNA was extracted from the sand flies, submitted to sequence independent amplification and high-throughput pyrosequencing. This is the first time an unbiased and comprehensive transcriptomic approach has been used to analyse an infectious disease vector in its natural environment. Transcripts identified in the sand flies showed characteristic profiles which correlated with the environment of origin and with taxa previously identified in these same specimens. Among these, various genes represented putative targets for vector control via RNA interference (RNAi).
Highlights
Leishmaniasis, a vector-borne neglected infectious disease of worldwide incidence, comprises two major diseases: visceral leishmaniasis (VL), which is fatal if untreated, and the cutaneous form (CL), which can heal spontaneously but leaves disfiguring scars [1]
Since VL results in death if not treated, the majority of deaths caused by leishmaniasis go unrecognized and, even with access to treatment, VL may result in case-fatality rates of 10–20% [6,7,8], the reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden [9]
Due to the fact that total RNA was amplified using a modified sequenceindependent amplification protocol [25] and, for this, first-strand reverse transcription was initiated with a random octamer linked to a specific primer sequence, an unbiased random collection of transcripts was obtained for each sample
Summary
Leishmaniasis, a vector-borne neglected infectious disease of worldwide incidence, comprises two major diseases: visceral leishmaniasis (VL), which is fatal if untreated, and the cutaneous form (CL), which can heal spontaneously but leaves disfiguring scars [1]. Leishmaniasis is classified as one of the ‘‘most neglected diseases’’ [2] due to the limited resources invested in its diagnosis, treatment and control and its strong association with poverty [3]. The estimated burden for this disease places it second in mortality and fourth in morbidity among all tropical diseases [4]. Since VL results in death if not treated, the majority of deaths caused by leishmaniasis go unrecognized and, even with access to treatment, VL may result in case-fatality rates of 10–20% [6,7,8], the reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden [9]. Inadequate access to healthcare causes delays in appropriate diagnosis and treatment and accentuates leishmaniasis morbidity and mortality [3]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
